Healthcare provider profile · identity verified

Banani Saha, MD

Family Practice · MECHANICSBURG, PA · NPI 1003875410

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	550	158
Lisinopril	Lisinopril	472	126
Amlodipine Besylate	Amlodipine Besylate	418	119
Levothyroxine Sodium	Levothyroxine Sodium	260	68
Losartan Potassium	Losartan Potassium	234	68
Simvastatin	Simvastatin	191	61
Omeprazole	Omeprazole	180	60
Metformin Hcl	Metformin Hcl	176	54
Rosuvastatin Calcium	Rosuvastatin Calcium	154	44
Prednisone	Prednisone	143	115
Metoprolol Succinate	Metoprolol Succinate	140	42
Furosemide	Furosemide	139	48
Alendronate Sodium	Alendronate Sodium	133	30
Hydrochlorothiazide	Hydrochlorothiazide	128	38
Lorazepam	Lorazepam	121	26
Trazodone Hcl	Trazodone Hcl	112	34
Pantoprazole Sodium	Pantoprazole Sodium	106	31
Gabapentin	Gabapentin	105	30
Sertraline Hcl	Sertraline Hcl	102	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	85	27
Famotidine	Famotidine	81	23
Jardiance	Empagliflozin	77	19
Clonazepam	Clonazepam	73	14
Tramadol Hcl	Tramadol Hcl	72	18
Montelukast Sodium	Montelukast Sodium	71	19
Metformin Hcl Er	Metformin Hcl	69	17
Fluticasone Propionate	Fluticasone Propionate	67	36
Escitalopram Oxalate	Escitalopram Oxalate	65	19
Albuterol Sulfate Hfa	Albuterol Sulfate	64	42
Azithromycin	Azithromycin	63	57
Eliquis	Apixaban	62	15
Tamsulosin Hcl	Tamsulosin Hcl	61	18
Chlorthalidone	Chlorthalidone	60	17
Alprazolam	Alprazolam	55	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	55	16
Allopurinol	Allopurinol	52	14
Zolpidem Tartrate	Zolpidem Tartrate	52	12
Atenolol	Atenolol	50	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	18
Potassium Chloride	Potassium Chloride	47	14
Celecoxib	Celecoxib	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Glimepiride	Glimepiride	46	13
Glipizide	Glipizide	45	11
Citalopram Hbr	Citalopram Hydrobromide	44	12
Clonidine Hcl	Clonidine Hcl	44	13
Glipizide Er	Glipizide	42	13
Buspirone Hcl	Buspirone Hcl	41	14
Synthroid	Levothyroxine Sodium	41	11
Duloxetine Hcl	Duloxetine Hcl	39	11
Doxycycline Hyclate	Doxycycline Hyclate	37	33
Azelastine Hcl	Azelastine Hcl	35	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Bupropion Xl	Bupropion Hcl	34	11
Cephalexin	Cephalexin	34	30
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Ozempic	Semaglutide	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Carvedilol	Carvedilol	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	29
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Cefuroxime	Cefuroxime Axetil	28	24
Fenofibrate	Fenofibrate	27	suppressed
Methylprednisolone	Methylprednisolone	27	25
Spironolactone	Spironolactone	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Nystatin	Nystatin	22	11
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Topiramate	Topiramate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Fluconazole	Fluconazole	19	15
Pregabalin	Pregabalin	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	13
Donepezil Hcl	Donepezil Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Mupirocin	Mupirocin	15	11
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Ramipril	Ramipril	14	suppressed
Hydrocortisone	Hydrocortisone	13	11
Jantoven	Warfarin Sodium	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error